HIGHLIGHTS
- who: from the Northwestern University, Evanston, IL, USA have published the research: Journal of Pharmaceutics and Therapeutics Use of Ketamine to Treat Depressive Symptoms in Schizoaffective Disorder, in the Journal: (JOURNAL)
- future: Research is needed to replicate these findings to gain a better understanding of the effects ketamine may have on patients with schizoaffective disorder.
SUMMARY
Schizoaffective disorder is a chronic mental disorder characterized by psychotic symptoms such as delusions, visual and/or auditory hallucinations, as well as symptoms of either treatment resistant depression (TRD) or bipolar depression. Patients are diagnosed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.